| Project | Indication | Stage of R&D | Target & Modality |
|---|---|---|---|
| MBT-C101 |
Breast cancer, Colorectal cancer |
Candidate to Preclinical |
mtPI3Kα Degrader |
| MBT-C201 | Gastric cancer, Breast cancer |
Early lead | |
| MBT-K101 |
Colorectal cancer, Castration-resistant prostate cancer |
Candidate | ACK1 Dual Inhibitor |
| MBT-K201 |
Biliary tract cancer, Bladder cancer |
Lead | 3rd generation Irreversible Inhibitor |